Safety of Infusing Ipilimumab Over 30 Minutes

PURPOSE: The approved dose of ipilimumab is 3 mg/kg infused over 90 minutes; however, in clinical trials, 10 mg/kg has also been infused over 90 minutes. At this higher dose, patients receive 3 mg/kg within the first 27 minutes of treatment. We sought to determine whether the standard dose of 3 mg/k...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Oncol
Päätekijät: Momtaz, Parisa, Park, Vivian, Panageas, Katherine S., Postow, Michael A., Callahan, Margaret, Wolchok, Jedd D., Chapman, Paul B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2015
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5087314/
https://ncbi.nlm.nih.gov/pubmed/26124475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.61.0030
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia